Financial informations
Financial results at March 31th : 9 months 2021/2022
Unaudited turnover for the 9 months period ending 31 March 2022 amounted to €3,141.7m, up 6.7% compared to the same period of the previous year.
Ramsay Santé steps up its ESR strategy with its maiden Euro Private Placement Sustainability-Linked issue
Ramsay Santé pursues its sustainable commitments with the launch of its third financial instrument linked to sustainable development goals.
Quarterly results at September 30, 2021
A continued positive development in the Nordics but a more complicated than expected recovery in business in France due to a fourth wave of Covid, and staff challenges.

Universal Registration Document as of June 30, 2021
Final annual results at the end of June 2021
Confirmation of data published at the end of August 2021
Date of approval of the final consolidated financial statements for the year ending June 2021
It is now expected that the final consolidated financial statements for the year ended June 2021 will be approved by the Board of Directors at its meeting on October 20, 2021
Provisional annual results at the end of June 2021
Strong financial results demonstrating the relevance of our strategic move as a global health provider in Continental Europe, in a Covid context where Ramsay Santé has kept on playing a critical role to take care of patients.

Ramsay Santé tops up its collateral trust (created in 2018), making it one of the largest (€186 m) on the French market and the first to be linked to ESG criteria
Ramsay Santé is now continuing its refinancing and sustainable commitment drive with this second financial instrument indexed to environmental objectives.
